Aptevo Therapeutics says holders exercise existing warrants for 254,922 shares at USD 4.03 each

• Aptevo closed a warrant inducement deal. Holders exercised existing warrants for 254,922 shares at USD 4.03.
• Issued unregistered Inducement Warrants for 1,274,610 shares. Exercise price USD 4.03. Exercisable post stockholder approval. Five-year term.
• PIPE sold 861,708 unregistered shares at USD 4.03, or Pre-Funded Warrants. Issued Common Warrants for 4,308,540 shares at USD 4.03.
• PIPE Pre-Funded Warrants are exercisable immediately. Common Warrants require stockholder approval. Both sets expire five years from approval.
• Gross proceeds totaled about USD 4.5 million. Company will file an SEC registration statement covering resale, including warrant shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aptevo Therapeutics Inc. published the original content used to generate this news brief on August 13, 2026, and is solely responsible for the information contained therein.